2024 US POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies

2024 US POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies

  • July 2020 •
  • 1172 pages •
  • Report ID: 5878746 •
  • Format: PDF
2024 US POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies

This new 1,172-page report contains 256 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. The report is available by section, and can be customized to specific information needs and budget.This report will help diagnostic product suppliers develop effective business, RandD and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

-Home/Personal Testing       
- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers
  
and by test category:

- Routine and Special Chemistry   
- Microbiology/Infectious Diseases   
- Hematology          
- Flow Cytometry         
- Coagulation     
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in RandD.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.

Contains 1,172 pages and 256 tables



Companies Profiled

Competitive Assessments
Abbott
Accriva
Agilent Technologies
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
bioMerieux
Bio-Rad
Cepheid
Chrono-Log
Corgenix
Decode Genetics
Diagnostica Stago
Diamedix
DiaSorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Grifols
Helena Laboratories
Hologic
Horiba
Instrumentation Laboratory/Werfen
Kyowa Medex
Leica Biosystems
Lonza
Nihon Kohden
Ortho-Clinical Diagnostics
Polymedco
Qiagen
Roche
SDIX
Sekisui Diagnostics
Sequenom
Siemens Healthineers
Sienco
Sysmex
Takara Bio
Thermo Fisher
Tosoh
Wako